A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease

Ko, WKD; Li, Q; Cheng, LY; Morelli, M; Carta, M; Bezard, E

Ko, WKD (reprint author), Motac Neurosci Ltd, POB 363, Manchester M15 6WE, Lancs, England.

EUROPEAN JOURNAL OF PHARMACOLOGY, 2017; 813 ( ): 10

Abstract

Eltoprazine, a serotonergic (5-HT)(1A/B) receptor agonist, is a potential treatment for L-DOPA-induced dyskinesia (LID) in Parkinson's disease (PD) bu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索